Name
Nordaid OÜ
Registry code
12082150
VAT number
EE101536305
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.03.2011 (13)
Financial year
01.01-31.12
Capital
2 520.00 €
Activity
21101 - Manufacture of basic pharmaceutical products
951 047 €
20 131 €
2%
2 027 €
(estimate is approximate)
389 842 €
9
Submitted
No tax arrears
5%
2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Kalle Kõre 15.03.1970 (54) | 51% - 1 285.00 EUR | Board member | Direct ownership | |
| OÜ Callimachus 11303301 | 49% - 1 235.00 EUR | - | - | |
| Ken-Marti Vaher 05.09.1974 (50) | - | - | Indirect ownership |
| 2019 27.10.2020 | 2020 24.06.2021 | 2021 30.06.2022 | 2022 10.03.2023 | 2023 14.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 312 824 € | 781 936 € | 1 134 562 € | 856 338 € | 951 047 € |
| Net profit (loss) for the period | 23 508 € | 178 845 € | 39 441 € | 106 491 € | 20 131 € |
| Profit Margin | 8% | 23% | 3% | 12% | 2% |
| Current Assets | 148 840 € | 416 467 € | 362 889 € | 357 077 € | 215 990 € |
| Fixed Assets | 982 € | 575 € | 26 573 € | 485 945 € | 971 699 € |
| Total Assets | 149 822 € | 417 042 € | 389 462 € | 843 022 € | 1 187 689 € |
| Current Liabilities | 104 888 € | 193 263 € | 126 242 € | 329 037 € | 440 195 € |
| Non Current Liabilities | - | - | - | 144 274 € | 357 652 € |
| Total Liabilities | - | - | - | 473 311 € | 797 847 € |
| Share Capital | - | - | - | - | - |
| Equity | 44 934 € | 223 779 € | 263 220 € | 369 711 € | 389 842 € |
| Employees | 1 | 1 | 5 | 9 | 9 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 180 432.78 € | 4 663.55 € | 25 676.04 € | 8 |
| 2023 Q4 | 293 407.18 € | 6 500.96 € | 29 342.17 € | 9 |
| 2023 Q3 | 276 442.74 € | 15 130.58 € | 31 958.26 € | 7 |
| 2023 Q2 | 151 594.54 € | 1 573.37 € | 29 667.58 € | 9 |
| 2023 Q1 | 227 386.91 € | - | 27 831.71 € | 9 |
| 2022 Q4 | 200 061.75 € | - | 24 313.71 € | 9 |
| 2022 Q3 | 117 871.95 € | 754.23 € | 25 030.84 € | 9 |
| 2022 Q2 | 275 479.72 € | - | 23 084.28 € | 9 |
| 2022 Q1 | 271 117.37 € | - | 20 348.58 € | 9 |
| 2021 Q4 | 204 098.25 € | 14 181.8 € | 16 748.21 € | 8 |
| 2021 Q3 | 382 141.19 € | - | 10 245.55 € | 8 |
| 2021 Q2 | 427 650.22 € | - | 6 583.62 € | 4 |
| 2021 Q1 | 316 823.39 € | - | 4 251 € | 3 |
| 2020 Q4 | 238 242.27 € | - | 5 668 € | 1 |
| 2020 Q3 | 168 808.39 € | - | 4 251 € | 1 |
| 2020 Q2 | 131 598.79 € | - | 4 251 € | 1 |
| 2020 Q1 | 101 871.67 € | - | 4 024.28 € | 1 |
